Schizophrenia News and Research

Latest Schizophrenia News and Research

Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

Twenty-four hours of sleep deprivation can lead to conditions in healthy persons similar to the symptoms of schizophrenia. This discovery was made by an international team of researchers under the guidance of the University of Bonn and King's College London.

7 Jul 2014

Researchers reveal how schizophrenia-linked genetic variation alters skeletons of developing brain cells

Johns Hopkins researchers have begun to connect the dots between a schizophrenia-linked genetic variation and its effect on the developing brain. As they report July 3 in the journal Cell Stem Cell, their experiments show that the loss of a particular gene alters the skeletons of developing brain cells, which in turn disrupts the orderly layers those cells would normally form.

4 Jul 2014

Cannabis use and schizophrenia ‘share genetic risk’

Variants of genes that predispose people to developing schizophrenia also predispose them to using cannabis, a study of more than 2000 people has found.

3 Jul 2014

Maternal inflammatory marker linked to children’s schizophrenia risk

The children of women who have elevated levels of the inflammatory marker C-reactive protein during pregnancy have an increased risk of developing schizophrenia, research suggests.

3 Jul 2014

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

3 Jul 2014

More music therapists needed in psychiatric health care, says researcher

Music can help those without the means to express themselves to communicate. There is a need for more music therapists in psychiatric health care, says researcher Karin Mössler at Uni Research in Bergen, Norway.

1 Jul 2014

Research finding may accelerate development of treatments for PTSD

Scientists at Yerkes National Primate Research Center, Emory University have identified a drug that appears to make memories of fearsome events less durable in mice.

1 Jul 2014

Higher risk of psychiatric disorders found in children born to women with fertility problems

Children born to women with fertility problems have a higher risk of psychiatric disorders than naturally conceived children. The increase in risk was described as "modest" by researchers from Denmark, but was found to persist throughout childhood and into young adulthood.

30 Jun 2014

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Autism Speaks, the world's leading autism science and advocacy organization, today announced it has awarded more than $600,000 in funding for six promising scientists pursuing academic training in translational research.

28 Jun 2014

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Insight has ‘trait-like properties’ in psychosis

Poor insight persists in many patients after their first episode of psychosis and is predicted by insight at baseline, report researchers.

26 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

The University of Maryland School of Medicine's Maryland Psychiatric Research Center, a research center in the School's Department of Psychiatry, was awarded a $10.7 million grant from the National Institutes of Health to establish a Silvio O. Conte Neuroscience Research Center that will examine the causes of schizophrenia and search for possible new treatments.

25 Jun 2014

New study finds genetic links between schizophrenia risk and cannabis use

Genes that increase the risk of developing schizophrenia may also increase the likelihood of using cannabis, according to a new study led by King's College London, published today in Molecular Psychiatry.

25 Jun 2014

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

This report estimated the effect of the Affordable Care Act (ACA) on 14 large and diverse cities: Los Angeles, Chicago, Houston, Philadelphia, Phoenix, Indianapolis, Columbus, Charlotte, Detroit, Memphis, Seattle, Denver, Atlanta, and Miami.

21 Jun 2014

Schizophrenia focus narrowed to dentate gyrus

The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.

19 Jun 2014

CBT reduces urge to obey command hallucinations

The COMMAND trial shows that cognitive behaviour therapy can bring about a “clinically meaningful” reduction in the rate at which patients comply with command hallucinations.

19 Jun 2014

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Alkermes plc today announced the presentation of data from its phase 3 clinical trial of aripiprazole lauroxil, an investigational drug candidate in development for schizophrenia, at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Fla.

18 Jun 2014

Moving during childhood linked to increased schizophrenia risk

Childhood residential mobility is associated with an increased risk of psychotic disorders, particularly schizophrenia, during adulthood, according to results of a study conducted in Denmark.

16 Jun 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

Researchers reveal how schizophrenia-linked genetic variation alters skeletons of developing brain cells

Cannabis use and schizophrenia ‘share genetic risk’

Maternal inflammatory marker linked to children’s schizophrenia risk

Researchers identify genetic mutation that may cause parkinsonism in young people

More music therapists needed in psychiatric health care, says researcher

Research finding may accelerate development of treatments for PTSD

Higher risk of psychiatric disorders found in children born to women with fertility problems

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Researchers give new, unprecedented 3-D view of most important brain receptors

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Insight has ‘trait-like properties’ in psychosis

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

New study finds genetic links between schizophrenia risk and cannabis use

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

Schizophrenia focus narrowed to dentate gyrus

CBT reduces urge to obey command hallucinations

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Moving during childhood linked to increased schizophrenia risk

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Schizophrenia News and Research

Latest Schizophrenia News and Research

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in